| A Drug Interaction Study With Albiglutide and Warfarin (NCT01147731) | GlaxoSmithKline | 2010-06-04 |
| Study HZA106829: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics (NCT01134042) | GlaxoSmithKline | 2010-06-01 |
| Dose Ranging Study of Pazopanib to Treat Neovascular Age-Related Macular Degeneration (NCT01134055) | GlaxoSmithKline | 2010-06-01 |
| Cancer in Patients With Gabapentin (GPRD) (NCT01236053) | GlaxoSmithKline | 2010-06-01 |
| HZA113091 Efficacy and Safety of Fluticasone Furoate/Vilanterol (GW642444) in Adults and Adolescents (NCT01147848) | GlaxoSmithKline | 2010-06-01 |
| A Drug Interaction Study Between Simvastatin, Atorvastatin, Rosuvastatin, and GSK2248761 in Healthy Subjects. (NCT01138072) | GlaxoSmithKline | 2010-06-01 |
| Safety and Efficacy Study for Solid Tumor Patients Treated With Eltrombopag (NCT01147809) | GlaxoSmithKline | 2010-06-01 |
| An Open Label Study To Investigate the Pharmacokinetics and Pharmacodynamics of Repeat Escalating Doses of the Oral AKT Inhibitor GSK2141795 by 18F FDG PET Analysis in Subjects With Ovarian Cancer (NCT01266954) | GlaxoSmithKline | 2010-06-01 |
| Establishing the Benefits of Adherence to Enlarged Prostate Treatment: A Validation Study Linking Adherence to Outcomes Using the Market Scan Database (NCT01381510) | GlaxoSmithKline | 2010-06-01 |
| Coreg and HSRs-Updated Analysis (NCT01316952) | GlaxoSmithKline | 2010-06-01 |
| Bupropion and Specific Cardiovascular Malformations (NCT01165255) | GlaxoSmithKline | 2010-06-01 |
| Study of Natural History of Human Papillomavirus (HPV) Infections in Adult Women With Recurrent Conizations in Norway (NCT00924794) | GlaxoSmithKline | 2010-06-01 |
| GSK2018682 FTIH in Healthy Volunteers (NCT01387217) | GlaxoSmithKline | 2010-05-21 |
| Modulation of Abeta Levels by GSK933776 in Alzheimer's Disease Patient (NCT01424436) | GlaxoSmithKline | 2010-05-19 |
| A Drug Interaction Study of Simvastatin and Albiglutide (NCT01147692) | GlaxoSmithKline | 2010-05-19 |
| A Single Dose Study to Determine the Excretion, Balance and Metabolic Disposition of Radiolabelled GW642444. (NCT01286831) | GlaxoSmithKline | 2010-05-18 |
| Study of GSK Biologicals' Influenza Vaccine Arepanrix™ in Japanese Adults 65 Years of Age or Older (NCT01114620) | GlaxoSmithKline | 2010-05-17 |
| Study to Look at and Compare How Inhaled and Intravenous Fluticasone Furoate and GW642444 Are Processed by the Body in Healthy Subjects (NCT01299558) | GlaxoSmithKline | 2010-05-17 |
| Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants (NCT01090453) | GlaxoSmithKline | 2010-05-17 |
| Trial of Otelixizumab for Adolescents and Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-2 (NCT01123083) | GlaxoSmithKline | 2010-05-17 |
| Bioequivalence Study of Montelukast 5 mg Chewable (NCT01863654) | GlaxoSmithKline | 2010-05-16 |
| Bioequivalence Study of Montelukast 10 mg Tablets (NCT01943942) | GlaxoSmithKline | 2010-05-16 |
| Ofatumumab Cardiac Repolarization (QTc) Study in Fludarabine-Refractory Chronic Lymphocytic Leukemia Subjects (NCT01110031) | GlaxoSmithKline | 2010-05-13 |
| Study to Evaluate the Immunogenicity and Reactogenicity of a Booster Dose of GSK2036874A Vaccine in Healthy Toddlers (NCT01106092) | GlaxoSmithKline | 2010-05-13 |
| Repeat Dose Subcutaneous Rhumatoid Arthritis Efficacy Study (NCT01101555) | GlaxoSmithKline | 2010-05-12 |
| A Study to Assess the Relative Bioavailability of Four New Formulations of GSK1605786 in Healthy Subjects (NCT01114607) | GlaxoSmithKline | 2010-05-05 |
| Safety, Pharmacokinetics (PK) of AKT and MEK Combination (NCT01138085) | GlaxoSmithKline | 2010-05-04 |
| Bioequivalence Study of Escitalopram Tablets 10 mg (NCT01745601) | GlaxoSmithKline | 2010-05-04 |
| Regulatory AVAMYS Nasal Spray PMS (NCT01001130) | GlaxoSmithKline | 2010-05-01 |
| Korean Practice Patterns for Screening PCA(Prostate Cancer) (NCT01371513) | GlaxoSmithKline | 2010-05-01 |
| Post-marketing Surveillance Study With GSK Biologicals' Pneumococcal Vaccine in Healthy Infants in Philippines (NCT01046097) | GlaxoSmithKline | 2010-05-01 |
| Clinical and Economic Burden of Uncontrolled Epilepsy: Analyses From a Medicaid Database and a Private Health Plan Database (NCT01390909) | GlaxoSmithKline | 2010-05-01 |
| JCP Study of Investigation of Patient Background Characteristics (NCT01332474) | GlaxoSmithKline | 2010-05-01 |
| Pharmacokinetics and PharmacoDynamics of GW685698 in Paedeatric Asthmatic Patients (NCT01332292) | GlaxoSmithKline | 2010-05-01 |
| A Study for Evaluation of GSK Biologicals' Pandemic Influenza Vaccine (NCT00866580) | GlaxoSmithKline | 2010-05-01 |
| A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment. (NCT01098539) | GlaxoSmithKline | 2010-05-01 |
| A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide. (NCT01128894) | GlaxoSmithKline | 2010-05-01 |
| Randomised Study Comparing the Effects of Inhaled FF/GW642444M Combination, FF and GW642444M on an Allergen Induced Asthmatic Response (NCT01128595) | GlaxoSmithKline | 2010-05-01 |
| A Pharmacokinetic Study to Compare Sustained Release and Standard Paracetamol Formulations. (NCT01551797) | GlaxoSmithKline | 2010-05-01 |
| Assessment of the Serologic Response to Porcine Circovirus Type 1 (PCV-1) in the Serum of Infants and Toddlers, Following Administration of IPV (Inactivated Poliovirus Vaccine)-Containing Vaccines (NCT01651247) | GlaxoSmithKline | 2010-05-01 |
| A Longitudinal 2-year Bone Marrow Study of Eltrombopag in Previously Treated Adults, With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) (NCT01098487) | GlaxoSmithKline | 2010-05-01 |
| Chronic Obstructive Pulmonary Disease (COPD) Post-hospitalization Study (NCT01110200) | GlaxoSmithKline | 2010-04-30 |
| AVODART® Alopecia Post-marketing Surveillance (PMS) (NCT01004809) | GlaxoSmithKline | 2010-04-29 |
| A Study in Adult Subjects With Chronic Hepatitis B Infection to Support the Development of Immunological Assays (NCT01098006) | GlaxoSmithKline | 2010-04-29 |
| GSK573719 IV Enabling Study (NCT01110018) | GlaxoSmithKline | 2010-04-28 |
| Safety, Pharmacodynamics and Pharmacokinetics of GSK2136525 Repeat Dose in Rheumatoid Arthritis (NCT01077531) | GlaxoSmithKline | 2010-04-28 |
| Healthy Volunteer Pilot Study Using 3 Types of Modified Release Formulations of Firategrast to Investigate How Quickly Absorption From the Digestive System Takes Place. (NCT01424462) | GlaxoSmithKline | 2010-04-19 |
| Pharmacokinetics and Safety of GSK1325756 in Elderly Subjects and Adult Subjects of in the Fed and Fasted States and in the Presence of a Proton Pump Inhibitors (NCT01209104) | GlaxoSmithKline | 2010-04-14 |
| A Study to Investigate the Interaction of GSK1292263 With Rosuvastatin and Simvastatin in Healthy Subjects (NCT01101568) | GlaxoSmithKline | 2010-04-14 |
| Study to Assess the Safety of GSK Biologicals' Liquid Human Rotavirus Vaccine in Healthy Infants (NCT01107587) | GlaxoSmithKline | 2010-04-13 |
| Trial to Evaluate the Safety and the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in Healthy Children (NCT01096056) | GlaxoSmithKline | 2010-04-05 |
| Booster and Catch-up Vaccination With Vaccine GSK1024850A (NCT01030822) | GlaxoSmithKline | 2010-04-02 |
| Phase I/II Study of Lapatinib in Combination With Paclitaxel as 1L Chemotherapy for ErbB2-positive MBC (NCT01138046) | GlaxoSmithKline | 2010-04-01 |
| 31P MRS Ischaemic Exercise Optimisation and COPD (NCT01476072) | GlaxoSmithKline | 2010-04-01 |
| A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GSK1358820 (Botulinum Toxin Type A) in Chinese Subjects With Post-stroke Upper Limb Spasticity (NCT01153815) | GlaxoSmithKline | 2010-04-01 |
| Safety and Immune Response of One-Dose of Candidate H1N1 Influenza Vaccine GSK2340274A in Adults (NCT01008956) | GlaxoSmithKline | 2010-04-01 |
| A Study in Healthy Adults Having Received a Single Vaccine Administration to Support the Development of Immunological Assays (NCT01099488) | GlaxoSmithKline | 2010-04-01 |
| Serological Response to Porcine Circovirus Type 1 (PCV-1) and PCV-1 DNA in Stools of Infants Following Administration of Rotarix™ (NCT01511133) | GlaxoSmithKline | 2010-04-01 |
| Demonstrating the Clinical and Economic Benefit of 5 Alpha Reductase Inhibitor Adherence in Benign Prostatic Hyperplasia (NCT01334723) | GlaxoSmithKline | 2010-04-01 |
| Benign Prostatic Hypertrophy Treatment Patterns & Outcomes: Marketscan (NCT01323998) | GlaxoSmithKline | 2010-04-01 |
| Study of a Birth Dose of GlaxoSmithKline Biologicals' 251154 Vaccine (NCT01110044) | GlaxoSmithKline | 2010-04-01 |
| Dose Ranging Study of Albiglutide in Japanese Subjects (NCT01098461) | GlaxoSmithKline | 2010-04-01 |
| Effect of a Commercial Cosmetic Mouth Rinse on Plaque Re-growth (NCT01122862) | GlaxoSmithKline | 2010-04-01 |
| Study on the Prevalence of Human Papillomavirus Types in Women >= 15 Years of Age in the Kingdom of Saudi Arabia (NCT01213459) | GlaxoSmithKline | 2010-04-01 |
| GSK1358820 (Botulinum Toxin A) PhIII DB & OL Study in Patients With Axillary Hyperhidrosis (NCT01128738) | GlaxoSmithKline | 2010-04-01 |
| Pharmacokinetic Study to Compare Two Formulations of Paracetamol (NCT01767428) | GlaxoSmithKline | 2010-04-01 |
| An Efficacy and Safety Study of Fixed-dose Rosiglitazone/Glimepiride to Treat Chinese Type 2 Diabetes Patients (NCT01453049) | GlaxoSmithKline | 2010-04-01 |
| A Study to Compare Two Paracetamol Tablets (NCT01381640) | GlaxoSmithKline | 2010-04-01 |
| Bioequivalence Trial of Alprazolam 2 mg Tablets (NCT01745575) | GlaxoSmithKline | 2010-03-28 |
| Long-term Follow-up of Participants From Studies Evaluating GSK HIV Vaccine (NCT01092611) | GlaxoSmithKline | 2010-03-22 |
| An Evaluation of the Pharmacokinetics of an Oral Contraceptive (Brevicon) When Co-administered With Albiglutide . (NCT01077505) | GlaxoSmithKline | 2010-03-15 |
| Study to Evaluate the Safety of Rotarix™ in Chinese Children (NCT01086436) | GlaxoSmithKline | 2010-03-13 |
| A Safety Study to Evaluate Pazopanib Eye Drops in Healthy Volunteers (NCT01072214) | GlaxoSmithKline | 2010-03-09 |
| Safety and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine 1437173A in Healthy Ethnic Japanese Adults (NCT01086449) | GlaxoSmithKline | 2010-03-04 |
| Pharmacokinetic and Safety of GSK573719 and GW642444 Administered Individually and Concurrently, With Verapamilin in Healthy Subjects (NCT01128634) | GlaxoSmithKline | 2010-03-04 |
| A Clinical Study to Assess the Safety, Tolerability, and Activity of Oral SRT2104 Capsules Administered for 28 Days to Subjects With Type 2 Diabetes Mellitus (NCT01018017) | GlaxoSmithKline | 2010-03-03 |
| Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B Cell Lymphoma (NCT01014208) | GlaxoSmithKline | 2010-03-01 |
| Promacta Pregnancy Registry (NCT01064336) | GlaxoSmithKline | 2010-03-01 |
| Impact of Migraine on Work Productivity in Patients Treated With a Combination Product Containing Sumatriptan and Naproxen Sodium or Triptan Monotherapy (NCT01381497) | GlaxoSmithKline | 2010-03-01 |
| Safety Study of the Effects of Inhaled Fluticasone Furoate/GW642444 on the Hypothalamic-Pituitary-Adrenal (HPA) Axis (NCT01086410) | GlaxoSmithKline | 2010-03-01 |
| Immunogenicity and Safety Study of GSK Biologicals' Infanrix-IPV+Hib™ Vaccine (NCT01086423) | GlaxoSmithKline | 2010-03-01 |
| Study to Evaluate the Reactogenicity and Safety of Rotarix™ in Chinese Adults (NCT01162590) | GlaxoSmithKline | 2010-03-01 |
| Seroprevalence Study of Hepatitis A, Varicella-Zoster, Cytomegalovirus, Herpes Simplex and Bordetella Pertussis (NCT01160081) | GlaxoSmithKline | 2010-03-01 |
| Repeat Dose Safety and Efficacy Study for Compound to Treat Anemia (NCT01047397) | GlaxoSmithKline | 2010-03-01 |
| Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD) (NCT01138124) | GlaxoSmithKline | 2010-03-01 |
| Retrospective Study of Patients Who Were Treated With Fondaparinux Pre-, Peri- and/or Postpartum for Prophylaxis or Treatment of Venous Thromboembolism (NCT01004939) | GlaxoSmithKline | 2010-03-01 |
| Asthma Exacerbation Study (NCT01086384) | GlaxoSmithKline | 2010-02-22 |
| A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel Group Study of Six Months Treatment With Ropinirole PR as Adjunctive Therapy in Patients With Parkinson's Disease Who Are Not Optimally Controlled on L-Dopa (NCT01154166) | GlaxoSmithKline | 2010-02-15 |
| Safety and Efficacy of H1N1 Vaccines in Children Aged 6 Months to Less Than 10 Years of Age (NCT01051661) | GlaxoSmithKline | 2010-02-12 |
| NOGO-A in Multiple Sclerosis FTIH (NCT01424423) | GlaxoSmithKline | 2010-02-11 |
| Safety and Immune Response of Candidate H1N1 Influenza Vaccine GSK2340274A Following Seasonal Influenza Vaccination in Adults (NCT01059617) | GlaxoSmithKline | 2010-02-09 |
| PK Study of IV Formulation of GW856553 (NCT01039961) | GlaxoSmithKline | 2010-02-02 |
| Meta-analysis of Orlistat Laboratory Data From Placebo-controlled Clinical Trials (NCT01332448) | GlaxoSmithKline | 2010-02-01 |
| A Study to Investigate the Ability of GSK706769 to Maintain Clinical Remission After Withdrawal of Enbrel in Rheumatoid Arthritis Patients (NCT00979771) | GlaxoSmithKline | 2010-02-01 |
| Brain Metastasis in Breast Cancer Patients (NCT01077648) | GlaxoSmithKline | 2010-02-01 |
| Characterisation of Healthy Volunteers, Asthma and Chronic Obstructive Pulmonary Disease Patients for Inhalation Profile, Pharyngometry, Spirometric Indices and Lung Morphometry (NCT01345266) | GlaxoSmithKline | 2010-02-01 |
| Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery (NCT01444612) | GlaxoSmithKline | 2010-02-01 |
| Prevalence-based Health and Economic Model of the Bivalent Versus the Quadrivalent Human Papillomavirus (HPV) Vaccine (NCT01702337) | GlaxoSmithKline | 2010-02-01 |
| Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Children Aged 10 to Less Than 18 Years (NCT01035749) | GlaxoSmithKline | 2010-02-01 |
| Drug Use Investigation for Arepanrix® (H1N1) (NCT02069496) | GlaxoSmithKline | 2010-02-01 |